About this Webinar

NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the introduction of biosimilars and identify opportunities for technology solutions to reduce the administrative burden.

Watch this on demand webinar to learn more about:

  • Lessons learned from biosimilars in oncology treatment
  • The significant impact biosimilars will have on treatment considerations for autoimmune diseases
  • Steps payers can take to prepare for the changing landscape

Sneak Preview


Dr. Tiffany Avery HeadshotSPEAKER
Dr. Tiffany Avery, MD, MPH
NantHealth Chief Medical Officer
Clinical Oncologist
Dr. Neha Bhanusali HeadshotSPEAKER
Dr. Neha Bhanusali, MD, FACR
Associate Professor of Medicine, Rheumatology Faculty
University of Central Florida College of Medicine

Watch Webinar